K

Kaken Pharmaceutical Co Ltd
TSE:4521

Watchlist Manager
Kaken Pharmaceutical Co Ltd
TSE:4521
Watchlist
Price: 4 376 JPY 0.3% Market Closed
Market Cap: 165.7B JPY
Have any thoughts about
Kaken Pharmaceutical Co Ltd?
Write Note

Kaken Pharmaceutical Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kaken Pharmaceutical Co Ltd
Total Equity Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
K
Kaken Pharmaceutical Co Ltd
TSE:4521
Total Equity
ÂĄ142.5B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
8%
Takeda Pharmaceutical Co Ltd
TSE:4502
Total Equity
ÂĄ7.8T
CAGR 3-Years
14%
CAGR 5-Years
10%
CAGR 10-Years
13%
Daiichi Sankyo Co Ltd
TSE:4568
Total Equity
ÂĄ1.7T
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
6%
Otsuka Holdings Co Ltd
TSE:4578
Total Equity
ÂĄ2.6T
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
6%
Chugai Pharmaceutical Co Ltd
TSE:4519
Total Equity
ÂĄ1.6T
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
11%
Astellas Pharma Inc
TSE:4503
Total Equity
ÂĄ1.7T
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
3%

See Also

What is Kaken Pharmaceutical Co Ltd's Total Equity?
Total Equity
142.5B JPY

Based on the financial report for Jun 30, 2024, Kaken Pharmaceutical Co Ltd's Total Equity amounts to 142.5B JPY.

What is Kaken Pharmaceutical Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
8%

Over the last year, the Total Equity growth was 4%. The average annual Total Equity growth rates for Kaken Pharmaceutical Co Ltd have been 2% over the past three years , 3% over the past five years , and 8% over the past ten years .

Back to Top